Primary hyperoxaluria is a rare inherited condition where the liver produces too much oxalate, leading to recurrent kidney stones, kidney damage, and in severe cases, life-threatening complications affecting multiple organs throughout the body.

Understanding Primary Hyperoxaluria

Primary hyperoxaluria is a genetic disorder that affects how the body processes certain substances. In healthy individuals, the liver produces small amounts of oxalate, which is then filtered by the kidneys and removed through urine. However, in people with primary hyperoxaluria, the liver makes far too much oxalate due to missing or malfunctioning enzymes—proteins that help break down and process various compounds in the body.^[1]

When oxalate levels become too high, this substance combines with calcium to form hard crystals called calcium oxalate. These crystals can cluster together to create stones in the kidneys and urinary tract. Over time, the continuous formation of these crystals damages the kidneys, reducing their ability to function properly. As kidney function declines, even less oxalate can be removed from the body, creating a dangerous cycle.^[3]

In advanced stages of the disease, when the kidneys can no longer remove oxalate effectively, this substance begins to accumulate in other parts of the body. This widespread deposition of oxalate crystals is called systemic oxalosis, and it can affect bones, the heart, blood vessel walls, eyes, and other organs. Oxalate deposits in bones can make them fragile and prone to fractures, while deposits in the heart can interfere with its normal function.^[1]

Types of Primary Hyperoxaluria

There are three distinct types of primary hyperoxaluria, each caused by mutations in different genes and affecting different enzymes in the liver. While all three types result in excessive oxalate production, they vary in their severity and progression.^[1]

Primary hyperoxaluria type 1, commonly abbreviated as PH1, is the most common and typically the most severe form of the condition. It accounts for approximately 80 percent of all primary hyperoxaluria cases. PH1 is caused by mutations in the AGXT gene, which provides instructions for making an enzyme involved in breaking down a compound called glyoxylate. When this enzyme is deficient or absent, glyoxylate accumulates and gets converted into oxalate.^[1]

Primary hyperoxaluria type 2, or PH2, is similar to type 1 but generally follows a less aggressive course. This type accounts for about 10 percent of cases and is caused by mutations in the GRHPR gene. People with PH2 often develop kidney stones and kidney problems, but they typically progress to end-stage renal disease—a condition where the kidneys lose nearly all their ability to function—later in life compared to those with PH1.^[1]

Primary hyperoxaluria type 3, or PH3, is the rarest form and is caused by mutations in the HOGA1 gene. Individuals with PH3 often develop kidney stones in early childhood, but because so few cases have been documented, doctors are still learning about the full range of symptoms and long-term outcomes for this type.^[1]

How Common Is Primary Hyperoxaluria

Primary hyperoxaluria is considered a rare condition, affecting approximately 1 in 58,000 people worldwide. However, many experts believe the actual number of people living with this condition may be higher because it is frequently misdiagnosed or goes unrecognized entirely. The rarity of the disease, combined with its variable symptoms, means that many patients experience significant delays before receiving an accurate diagnosis.^[1]

Less than 1,000 people in the United States are currently diagnosed with primary hyperoxaluria, but genetic studies suggest that the true prevalence based on how many people carry the genetic mutations may be considerably higher than the diagnosed prevalence. This gap between genetic prevalence and diagnosed cases highlights the significant challenge of identifying this condition, particularly because kidney stones—the most common presenting symptom—are relatively common in the general population and can have many different causes.^[5]

When Does Primary Hyperoxaluria Appear

The age at which primary hyperoxaluria symptoms first appear can vary dramatically from person to person, even among family members who carry the same genetic mutation. Some infants develop severe symptoms before their first birthday, while others may not experience any problems until they are teenagers or adults. The average age when symptoms become noticeable is around 5 years old.^[5]

In primary hyperoxaluria type 1, kidney stones typically begin forming anywhere from childhood through early adulthood. Approximately 10 percent of individuals with PH1 present with symptoms during infancy, 70 percent during childhood or adolescence, and 20 percent during adulthood. When PH1 develops in infancy, it tends to be particularly severe. Studies show that about 50 percent of children who develop primary hyperoxaluria as infants will experience kidney failure by age 15, and approximately 80 percent will progress to kidney failure by age 30.^[3][5]

People with primary hyperoxaluria type 2 generally develop symptoms and complications later in life compared to those with type 1, though they still face significant health challenges. Type 3 primary hyperoxaluria often causes kidney stones to develop in early childhood, but because this form is so rare and not well studied, the typical age of onset and progression pattern remains less clearly defined.^[1]

What Causes Primary Hyperoxaluria

Primary hyperoxaluria is caused by inherited genetic mutations that prevent the liver from properly breaking down certain substances. These genetic changes are passed from parents to children in what scientists call an autosomal recessive pattern. This means that a person must inherit two copies of the mutated gene—one from each parent—to develop the condition. Parents who each carry one copy of the mutated gene typically do not show any symptoms themselves but have a 25 percent chance with each pregnancy of having a child with primary hyperoxaluria.^[1]

The specific gene affected determines which type of primary hyperoxaluria a person develops. In type 1, mutations in the AGXT gene lead to a deficiency of the enzyme alanine-glyoxylate aminotransferase, which normally works in specialized compartments of liver cells called peroxisomes. This enzyme plays a critical role in converting glyoxylate into glycine, a harmless amino acid. When the enzyme is missing or doesn’t work properly, glyoxylate accumulates and gets converted into oxalate instead.^[1]

In primary hyperoxaluria type 2, mutations affect the GRHPR gene, which provides instructions for making another enzyme involved in processing glyoxylate. Type 3 is caused by mutations in the HOGA1 gene, which is involved in breaking down certain amino acids that produce glyoxylate as an intermediate compound. Although researchers are still working to understand exactly how HOGA1 mutations lead to excess oxalate production, they know that all three types ultimately result in the liver making far more oxalate than the body can safely eliminate.^[1]

Who Is at Risk

The primary risk factor for developing primary hyperoxaluria is having two parents who each carry a mutation in one of the genes associated with the condition. Because this is a genetic disorder passed through families, biological relatives of someone with primary hyperoxaluria are at higher risk of either having the condition themselves or being carriers of the genetic mutation.^[1]

Siblings of a person diagnosed with primary hyperoxaluria have a one in four chance of also having the condition and a 50 percent chance of being carriers. This is why genetic counseling and testing for family members is strongly recommended once a diagnosis is made in one individual. Parents who have had one child with primary hyperoxaluria and are planning to have more children may benefit from working with genetic counselors who have experience with this rare condition.^[12]

Primary hyperoxaluria affects people of all ethnic backgrounds and geographic locations, though certain genetic mutations may be more common in specific populations. The condition occurs equally in males and females since the genes involved are not located on sex chromosomes.^[3]

Recognizing the Symptoms

The symptoms of primary hyperoxaluria can vary greatly depending on how much oxalate is being produced, how well the kidneys are functioning, and whether oxalate has begun to deposit in tissues beyond the kidneys. For many people, kidney stones are the first and most noticeable symptom. These stones can cause sudden, severe pain in the back, side, lower abdomen, or groin area. The pain often comes in waves and may be accompanied by nausea and vomiting.^[5]

Blood in the urine, medically called hematuria, is another common sign of primary hyperoxaluria. This happens when kidney stones or calcium oxalate crystals damage the lining of the urinary tract. The urine may appear pink, red, or brown, or blood may only be visible under a microscope during a urine test. Some people with primary hyperoxaluria experience frequent urinary tract infections, which develop when stones or crystals create conditions that allow bacteria to grow.^[5]

Beyond these urinary symptoms, people with primary hyperoxaluria may experience a frequent and urgent need to urinate, pain or burning during urination, or difficulty passing urine altogether. Some individuals can only urinate in very small amounts at a time, and in severe cases, complete blockage can occur. Fever and chills may develop if an infection is present.^[5]

Infants and young children with primary hyperoxaluria may show different signs than older children or adults. They might fail to grow and gain weight as expected, a condition doctors call failure to thrive. As the disease progresses and kidney function declines, additional symptoms may emerge, including fatigue, poor appetite, swelling in the legs and feet, and changes in urination patterns.^[5]

When primary hyperoxaluria advances to the stage where oxalate begins depositing throughout the body, symptoms can extend far beyond the urinary system. Bone pain and fractures may occur as calcium oxalate crystals weaken the skeleton. Vision problems can develop if crystals form in the eyes. Heart rhythm abnormalities and other cardiovascular symptoms may appear if the heart is affected. Skin discoloration and painful nodules can form when crystals deposit beneath the skin.^[1]

How the Disease Affects the Body

Understanding how primary hyperoxaluria changes normal body function helps explain why this condition can be so damaging. In a healthy person, the liver produces various substances as part of normal metabolism, including small amounts of oxalate. This oxalate travels through the bloodstream to the kidneys, which filter it out and send it to the bladder to be eliminated in urine. The process works smoothly because the amount of oxalate produced is relatively small and the kidneys can easily handle it.^[3]

In primary hyperoxaluria, the biochemical pathway that normally prevents oxalate overproduction is broken. The liver churns out oxalate in quantities far exceeding what the kidneys can safely eliminate. As oxalate passes through the tiny filtering units of the kidneys called nephrons, its high concentration causes it to crystallize with calcium. These sharp, hard crystals can form right inside the kidney tubules, blocking the flow of urine and causing direct damage to delicate kidney tissue.^[3]

The formation of kidney stones adds another layer of injury. When calcium oxalate crystals cluster together in the kidney’s collecting system, they form larger stones that can obstruct urine flow. This obstruction increases pressure within the kidney, which can damage the organ even if the stones don’t directly injure tissue. Stones moving through the ureter—the tube connecting the kidney to the bladder—cause the severe pain characteristic of kidney stone attacks. They can also damage the lining of the urinary tract and create openings for bacteria to enter, leading to infections.^[1]

Perhaps most concerning is the development of nephrocalcinosis, which refers to calcium deposits scattered throughout the kidney tissue itself rather than forming discrete stones. In nephrocalcinosis, tiny calcium oxalate crystals embed themselves in the kidney’s functional tissue, triggering chronic inflammation. This ongoing inflammatory process gradually destroys the microscopic filtering units, replacing healthy tissue with scar tissue. As more and more nephrons are lost, kidney function steadily declines.^[3]

Once kidney function drops below a certain threshold—typically when the glomerular filtration rate, a measure of how well kidneys filter blood, falls below 30 to 40 milliliters per minute—the kidneys can no longer keep up with the liver’s oxalate production. Oxalate begins accumulating in the bloodstream, reaching levels that are toxic to tissues throughout the body. This marks the transition from localized kidney disease to systemic oxalosis, a life-threatening condition.^[11]

Systemic oxalosis causes calcium oxalate to deposit in tissues far from the kidneys. In bones, these deposits interfere with normal bone structure and strength, making fractures more likely. In the heart, deposits can disrupt the electrical signals that coordinate heartbeats, potentially causing dangerous rhythm abnormalities. Blood vessel walls stiffen when infiltrated with crystals, which can contribute to circulation problems. When crystals form in the retina of the eye, they can affect vision. This widespread organ damage explains why primary hyperoxaluria can become fatal if not properly managed.^[1]

Preventing Primary Hyperoxaluria

Because primary hyperoxaluria is an inherited genetic condition, there is no way to prevent someone from being born with the disorder. However, families with a history of primary hyperoxaluria can take steps to prepare for the possibility that future children might be affected. Genetic counseling before pregnancy can help prospective parents understand their risks and explore their options.^[12]

For families who have already had one child with primary hyperoxaluria, genetic testing of the parents can confirm their carrier status and provide precise information about recurrence risk. Some families may choose to pursue prenatal testing during pregnancy, such as amniocentesis or chorionic villus sampling, which can detect genetic mutations in a developing fetus. These procedures involve collecting samples of fluid or tissue from the pregnancy and analyzing them for the specific gene mutations known to run in that family.^[12]

Once someone has been diagnosed with primary hyperoxaluria, early intervention becomes a form of prevention—not of the disease itself, but of its most serious complications. Staying extremely well-hydrated helps prevent kidney stones from forming by keeping urine diluted so that oxalate is less likely to crystallize. Following prescribed medication regimens can reduce oxalate production or help prevent crystals from aggregating. Regular monitoring allows doctors to detect declining kidney function early and adjust treatment strategies accordingly.^[3]

Preventing systemic oxalosis is a critical goal in managing primary hyperoxaluria. This requires aggressive treatment before kidney function declines too far. When detected early, newer therapies can significantly reduce oxalate production, giving the kidneys a better chance of maintaining their function over the long term. For some patients with certain genetic mutations, treatment with vitamin B6 can dramatically reduce oxalate levels and prevent disease progression.^[9]